Have £5k to invest? Here are 3 stocks I’d buy for an FTSE starter portfolio

Three shares for a starter portfolio in defensive, steady sectors backed by businesses with the potential to provide both income from dividends and growth.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

After first investing in tracker funds and managed funds, many investors aim to achieve higher returns by branching out into the shares of individual companies. I think that’s a good approach and I’d aim to build a starter portfolio with well-balanced FTSE shares.

To me, balance means looking for stocks in defensive, steady sectors backed by businesses with the potential to provide shareholders with both income from dividends and growth. Here are three names I’d be happy to allocate a £5k investment between.

Two income picks for a starter portfolio

In the FTSE 100, I’m keen on pharmaceutical giant GlaxoSmithKline (LSE: GSK). The company’s business has recovered in recent years from a period of falling annual earnings brought on by patent-expiry issues. Indeed, the research and development pipeline has helped the firm rebuild its earnings because of the new medicines and treatments the company is bringing to the market.

However, the stock remains depressed despite a decent record of consistent shareholder dividend payments through those uncertain years. And all the recent challenges relating to the Covid-19 crisis might not have helped investor sentiment. But with the shares close to 1,443p, the forward-looking dividend yield for 2021 is just above 5.5%.

I reckon that’s income worth collecting in a starter portfolio while waiting for growth in earnings to pick up in the years ahead.

Meanwhile, the FTSE 250’s Tate & Lyle (LSE: TATE) has a long and impressive record of shareholder dividend payments. And I reckon such income looks set to continue for shareholders in the coming years. Indeed, City analysts following the company predict modest increases in the dividend ahead.

The firm earns its living by providing ingredients and solutions to the food, beverage, and other industries. And the food sector, in general, as a defensive industry has enabled Tate & Lyle to trade through the current coronavirus crisis. But I reckon the defensive characteristics of the company’s underlying business will help it to prosper during general economic downturns in the future. As such, I reckon the stock is ideal for a long-term portfolio of shares.

With the share price near 674p, the forward-looking dividend yield for the trading year to March 2022 is a healthy-looking 4.5%. I think that’s income worth having.

Dividend growth potential

But I’d also go for business software and solutions provider Sage (LSE: SGE) in the FTSE 100. The firm has been moving its customers to cloud-based subscription services and building up some decent-looking recurring revenues. Indeed, earnings tend to be ‘sticky’ for the company because of all the inconvenience and costs faced by customers if they attempt to change suppliers.

As such, I see Sage as operating a business with defensive characteristics. And a multi-year record of generally rising cash flow and shareholder dividends gives me confidence in that assessment.

With the shares at 722p, the dividend yield isn’t as high as the other two companies but it does have a long history of growth, which I see as attractive. The forward-looking dividend yield for the trading year to September 2021 is just below 2.5%. I’d buy some of the shares now to hold for the long term.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has recommended GlaxoSmithKline and Sage Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

“The biggest lesson I’ve learned from the stock market in 2024 has been…”

Stock-market investing is subject to ups and downs (but, historically, ups overall!) What are you taking away from this year?

Read more »

Bearded man writing on notepad in front of computer
Investing Articles

Could a 2025 penny share takeover boom herald big profits for investors?

When penny share owners get caught up in a takeover battle, what might happen? Christopher Ruane looks at some potential…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

3 value shares for investors to consider buying in 2025

Some value shares blew the roof off during 2024, so here are three promising candidates for investors to consider next…

Read more »

Investing Articles

Can this takeover news give Aviva shares the boost we’ve been waiting for?

Aviva shares barely move as news of the agreed takeover of Direct Line emerges. Shareholders might not see it as…

Read more »

Investing Articles

2 cheap FTSE 250 growth shares to consider in 2025!

These FTSE 250 shares have excellent long-term investment potential, says Royston Wild. Here's why he thinks they might also be…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Has the 2024 Scottish Mortgage share price rise gone under the radar?

The Scottish Mortgage share price rise has meant a good year for the trust so far, but not as good…

Read more »

Investing Articles

Will the easyJet share price hit £10 in 2025?

easyJet has been trading well with rising earnings, which reflects in the elevated share price, but there may be more…

Read more »

Investing Articles

2 FTSE shares I won’t touch with a bargepole in 2025

The FTSE 100 and the FTSE 250 have some quality stocks. But there are others that Stephen Wright thinks he…

Read more »